Viemed Healthcare, Inc. (VMD)
- Previous Close
8.06 - Open
8.00 - Bid 8.05 x 100
- Ask 8.14 x 100
- Day's Range
7.97 - 8.16 - 52 Week Range
5.90 - 11.27 - Volume
137,674 - Avg. Volume
167,166 - Market Cap (intraday)
313.541M - Beta (5Y Monthly) 1.36
- PE Ratio (TTM)
32.36 - EPS (TTM)
0.25 - Earnings Date May 6, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
15.38
Viemed Healthcare, Inc., together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD. The company leases non-invasive and invasive ventilators, positive airway pressure machines (PAP), durable medical equipment, percussion vests, oxygen concentrators, and other medical equipment; and sells and rents HME devices. In addition, it provides neuromuscular care and oxygen therapy services; and sleep apnea management provides sleep solutions and/or equipment, such as PAP, automatic continuous positive airway pressure, and bi-level positive airway pressure machines. Further, the company offers in home sleep apnea testing services, as well as healthcare staffing and recruitment services. Viemed Healthcare, Inc. was founded in 2006 and is headquartered in Lafayette, Louisiana.
www.viemed.comRecent News: VMD
Performance Overview: VMD
Trailing total returns as of 4/24/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: VMD
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: VMD
Valuation Measures
Market Cap
313.54M
Enterprise Value
311.03M
Trailing P/E
32.36
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.78
Price/Book (mrq)
2.75
Enterprise Value/Revenue
1.70
Enterprise Value/EBITDA
8.48
Financial Highlights
Profitability and Income Statement
Profit Margin
5.60%
Return on Assets (ttm)
7.13%
Return on Equity (ttm)
9.71%
Revenue (ttm)
183.01M
Net Income Avi to Common (ttm)
10.24M
Diluted EPS (ttm)
0.25
Balance Sheet and Cash Flow
Total Cash (mrq)
12.84M
Total Debt/Equity (mrq)
9.06%
Levered Free Cash Flow (ttm)
22.29M